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AbsTrACT
background corticospinal tract (csT) degeneration 
and cortical atrophy are consistent features of 
amyotrophic lateral sclerosis (aLs). We hypothesised 
that neurite orientation dispersion and density imaging 
(NODDI), a multicompartment model of diffusion MRI, 
would reveal microstructural changes associated with 
aLs within the csT and precentral gyrus (pcG) ’in vivo’.
Methods 23 participants with sporadic aLs and 23 
healthy controls underwent diffusion MRI. Neurite 
density index (NDI), orientation dispersion index 
(ODI) and free water fraction (isotropic compartment 
(IsO)) were derived. Whole brain voxel-wise analysis 
was performed to assess for group differences. 
standard diffusion tensor imaging (DTI) parameters 
were computed for comparison. subgroup analysis 
was performed to investigate for NODDI parameter 
differences relating to bulbar involvement. correlation 
of NODDI parameters with clinical variables were also 
explored. The results were accepted as significant where 
p<0.05 after family-wise error correction at the cluster 
level, clusters formed with p<0.001.
results In the aLs group NDI was reduced in the 
extensive regions of the csT, the corpus callosum and the 
right pcG. ODI was reduced in the right anterior internal 
capsule and the right pcG. significant differences in NDI 
were detected between subgroups stratified according to 
the presence or absence of bulbar involvement. ODI and 
IsO correlated with disease duration.
Conclusions NODDI demonstrates that axonal 
loss within the csT is a core feature of degeneration 
in aLs. This is the main factor contributing to the 
altered diffusivity profile detected using DTI. NODDI 
also identified dendritic alterations within the pcG, 
suggesting microstructural cortical dendritic changes 
occur together with csT axonal damage.
INTroduCTIoN
In amyotrophic lateral sclerosis (ALS) degenera-
tion of the corticospinal system, cranial and spinal 
anterior horn motor neurons is a consistent clini-
copathological feature. However, the mechanisms 
underlying degeneration are not well understood.1 
It is unclear whether degeneration of corticospinal 
neurons represents a ‘dying back’ or ‘dying forward’ 
process,2 or whether these categories proposed 
from histological (ie, end stage) analyses are rele-
vant to the dynamics of cell damage and death in 
vivo. Understanding these processes is particularly 
relevant in the context of disease heterogeneity, since 
there may be common pathways linking the many 
genetic factors that contribute to pathogenesis.
In this context MRI has provided important 
insights into the localisation and extent, but not the 
fine detail, of cellular pathology in ALS. Arguably 
the most promising application has been diffusion 
tensor imaging (DTI), a quantitative MRI technique 
able to indirectly detect microstructural abnormali-
ties due to its sensitivity to water molecule displace-
ment within the tissue.3 4
However, DTI has limitations. First, changes to 
the DTI-derived indices of fractional anisotropy 
(FA) and mean diffusivity (MD) are non-specific.5 
Second, their interpretation in areas of complex 
axonal or dendritic architecture is not straight-
forward.6 7 Although indices such as the mode of 
anisotropy can provide some useful information 
in regions of crossing or fanning,8 a quantification 
of neurite density in such areas is challenging with 
DTI.
Recent developments in diffusion MRI have 
addressed some of the limitations of standard DTI 
and advanced capacity to characterise tissue micro-
structure. Neurite morphology evaluated by diffu-
sion MRI is correlated with histological analyses of 
neuropil in postmortem brain tissue9 and with the 
orientation of neurites in Golgi-impregnated brain 
tissue in vivo.10 Neurite orientation dispersion and 
density imaging (NODDI) provides a simplified 
yet sophisticated model of diffusion MRI, which 
separates the signal arising from three different 
tissue compartments: intraneurite water, extraneu-
rite water and cerebrospinal fluid (CSF).11 12 This 
model, recently validated with histological anal-
yses in multiple sclerosis spinal cord,13 facilitates 
the analysis of neurite morphology and focuses on 
quantifying the altered architecture of these multi-
faceted structures. NODDI estimates the density 
and fanning of neurites, as well as the partial volume 
contamination from CSF, using standard MRI scan-
ners within a clinically feasible time frame.
NODDI has been employed in a range of imaging 
studies, investigating the normal changes observed 
with ageing,14 as well as alterations associated with 
neurodegenerative diseases,15 16 white matter (WM) 
reorganisation following stroke17 and assessment 
of focal cortical dysplasia.18 NODDI has also been 
used to assess WM abnormalities in first-episode 
psychosis.19
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We used NODDI to analyse the mechanisms underlying the 
neurodegenerative changes in ALS.20 21 Our principal aim was 
to test the hypothesis that cortical pathology, such as loss or 
altered complexity of dendrites in the neuropil of the precentral 
gyrus (PCG), is occurring in ALS. We hypothesised that NODDI 
would detect reduced neurite density and orientation disper-
sion, accompanied by an increase in free water compartment. 
An additional aim was to clarify the microstructural changes 
within the WM, where we hypothesised that axonal degenera-
tion within the corticospinal tract (CST) would be detected as a 
loss of neurite density using NODDI.
We used NODDI in parallel with DTI to test the hypothesis 
that, by removing the confounding effect of orientation disper-
sion, NODDI would detect more axonal damage within the WM 
tracts than conventional DTI.
NODDI parameters were used to assess whether a combi-
nation of bulbar and limb involvement clinically would reveal 
differences when compared with limb-confined disease, to 
test the hypothesis that more widespread clinical involvement 
would relate to more extensive microstructural damage. Finally 
correlation of the NODDI parameters with clinical measures 
of ALS severity was explored with the anticipation that as clin-
ical measures of ALS severity reflect the underlying patholog-
ical processes, there may be correlation between these and the 
NODDI parameters.
This cross-sectional study using NODDI provides the first 
microstructural analysis of altered density and complexity of 
neurites in ALS. Analysing these characteristics and how they 
relate to the disease process ‘in vivo’ provides an exciting oppor-
tunity to advance the understanding of ALS pathogenesis.
MeThods
Participants
Participants with ALS (23; 16 men and 7 women; median age 
67 years, range 45–73 years) diagnosed with El Escorial defi-
nite, probable or laboratory-supported ALS were recruited from 
Brighton and Sussex University Hospitals NHS Trust. All had 
vital capacity (VC) values of over 60% predicted and capacity to 
give fully informed consent. Exclusion criteria were any contra-
indication to MRI or inability to tolerate lying flat for 1 hour 
due to either severe illness or respiratory compromise. Healthy 
controls (23; 14 men and 9 women, median age 64 years, range 
43–76 years) were included in the study for comparison. Genetic 
screening for known ALS mutations was not carried out for 
ethical reasons.
Clinical assessments of participants with ALs
Participants with ALS underwent a standardised neurolog-
ical examination, the Revised ALS Functional Rating Scale 
(ALSFRS-R)22 and the Edinburgh Cognitive and Behavioural 
ALS Screen (ECAS).23 The clinical assessment was used to stratify 
participants with ALS according to the site of ALS onset, disease 
distribution at the time of assessment, disease duration, Medical 
Research Council (MRC)24 manual muscle testing power score 
and upper motor neuron (UMN)3 score. The ALSFRS-R was 
used to calculate the monthly rate of change in ALSFRS-R 
(∆ALSFRS-R; reduction in ALSFRS-R score from 48 at baseline 
to the score at the time of assessment, divided by the number of 
months between the two scores), which we used as a substitute 
for the rate of progression. The ECAS was used to assess for the 
presence of any cognitive deficits related to the frontotemporal 
spectrum disorder (ALS-FTSD). These measures were all used to 
explore for associations between clinical phenotype and NODDI 
measures. All except for one of the participants with ALS were 
taking riluzole at the time of the clinical assessment and MRI.
MrI acquisition
MRI data were acquired on a 1.5T Siemens AVANTO scanner. 
The acquisition included the following:
1. Dual-echo turbo spin-echo (echo time (TE)=11 and 86 ms; 
repetition time (TR) =3040 ms; echo-train length=6; field 
of view (FoV)=240×210 mm2; matrix=256×224; slice 
thickness=5 mm).
2. Fast fluid-attenuated inversion recovery (TE=89 ms; 
TR=9720 ms; inversion time (TI)=2578; echo-train 
length=16; FoV=240×210 mm2; matrix=256×224; slice 
thickness=5 mm).
3. Volumetric high-resolution magnetization prepared rap-
id gradient echo (MPRAGE) (TE=3.57 ms; TR=2730 
ms; TI=100 ms; flip angle=70; FoV=256×240 mm2; ma-
trix=254×240; slice thickness=1 mm).
4. Multishell diffusion-weighted (DW) MRI was acquired with 
single-shot, twice-refocused pulse-gradient spin-echo (echo 
planar imaging; EPI),25 using 3 b-values (9 directions for 
b=300 smm−2, 30 directions with b=800 smm−2 and 60 
diffusion directions with b=2400 smm−2), optimised for 
NODDI.11 12 Ten non-diffusion-weighted (b=0) volumes 
were acquired. The following were additional acquisition 
parameters: TE=99 ms; TR=8400; FoV=240×240 mm2; 
matrix=96×96; slice thickness=2.5 mm.
In addition, we also obtained resting-state functional MRI and 
quantitative magnetisation transfer data (reported elsewhere). 
The total acquisition time was approximately 1 hour, although 
the time required for the sequences detailed above was 30 min.
Image processing
The DW images were first corrected for eddy-current distortions 
and for involuntary movement, using the following pipeline. A 
‘within-b-value’ coregistration was performed, and the average 
b=0, b=300, b=800 and b=2400 images were created. Each 
of these averages was coregistered to the mean b=0 image to 
obtain the transformation matching them. Each DW volume was 
realigned to the mean DW image with the same b-value, and the 
final transformation matching each DW volume with the b=0 
image was obtained by combining the matrices from either step. 
The b-matrices were rotated accordingly.26
The resulting images were skull-stripped using the FMRIB 
Software Library (FSL) brain extraction tool (http:// fsl. fmrib. 
ox. ac. uk/ fslwiki). Data were analysed using the software distrib-
uted by the developers of NODDI (http://www. nitrc. org/ proj-
ects/ noddi_ toolbox), implemented in Matlab (V.2012b), which 
yielded maps of the neurite density index (NDI), orientation 
dispersion index (ODI) and free water volume fraction for each 
participant (isotropic compartment (ISO)).11 Camino ( camino. 
org. uk) was used to fit the diffusion tensor to the same data using 
weighted least squares regression and to compute FA and MD 
maps.
The FA images were warped to common space to create a 
group-specific template, using Advanced Normalization Tools 
V.2.1.0 (http:// stnava. github. io/ ANTs). The resulting template 
was coregistered with the Montreal Neurological Institute (MNI) 
template from the FSL. The combination of these two transfor-
mations was applied to each NODDI parametric map, FA and 
MD. Three-dimensional Gaussian smoothing with full width at 
half maximum of 6 mm was performed in SPM12 (http://www. 
fil. ion. ucl. ac. uk/ spm/).
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Table 1 Participant demographics and clinical characteristics
Characteristics Participants with ALs (n=23) healthy controls (n=23)
Age, median (range), years 67 (45–73) 64 (43–76)
Sex, n
  Male 16 14
  Female 7 9
Site of onset 
  Limb 20 –
  Bulbar 3
Disease distribution clinically
  Bulbar and limb involvement 11 –
  Limb only involvement 12
Disease duration, median (range), months 17 (9–39) –
Slow vital capacity, median (range), % 79 (61–127) –
UMN score, median (range), out of a maximum of 16 
points
8 (3–16) –
Total MRC power score, median (range), out of a 
maximum of 220 points
188 (91–220) –
ALSFRS-R, median (range), out of a maximum of 48 points 40 (25–46) –
∆ALSFRS-R, median (range) 0.37 (0.09–1.33) –
ECAS total, median (range), out of a maximum of 136 
points
133 (88–135) –
ALS, amyotrophic lateral sclerosis; ALSFRS-R, Revised ALS Functional Rating Scale; ∆ALSFRS-R, rate of change per month in the Revised ALS Functional Rating Scale; ECAS, 
Edinburgh Cognitive and Behavioural ALS Screen; MRC, Medical Research Council; UMN, upper motor neuron.
statistical analysis
Statistical Package for the Social Sciences (SPSS IBM V. 22 for 
Windows) was used for statistical analysis of the demographic 
data.
Voxel-wise comparisons of whole brain NDI, ODI, ISO, 
FA and MD maps between the ALS and control groups were 
performed within the framework of the general linear model of 
SPM12.
The ALS group was then divided into two subgroups based on 
the presence or absence of bulbar symptoms (11 bulbar plus limb 
vs 12 limb alone). Voxel-wise whole brain analysis of NDI, ODI 
and ISO maps between the ALS subgroups was performed using 
the general linear model framework within SPM12.
Finally significant associations between the NODDI para-
metric maps and all of the clinical measures of ALS disease 
severity were assessed using SPM12.
In all analyses in SPM12, the age of the participant was used 
as a covariate. The results were accepted as significant where 
p<0.05 after family-wise error correction at the cluster level, 
where clusters were formed using p<0.001.
resuLTs
Participant characteristics
The demographics of all participants and the clinical characteris-
tics of participants with ALS are summarised in table 1. The two 
groups were well matched in terms of age (t=1.11, p=0.27) and 
gender (χ2=0.38, p=0.53).
Clinically the ALS group was phenotypically heterogeneous 
with a wide breadth of weakness, functional disability, rate of 
progression and cognitive deficit.
The majority of participants with ALS had the typical mixture 
of upper and lower motor neuron involvement. We recruited 
four ALS participants with lower motor neuron (LMN)-predom-
inant ALS (two flail arm, two flail leg) and one participant with 
UMN-predominant phenotype.
None of the participants with ALS fulfilled the revised diag-
nostic criteria for ALS-Frontotemporal Dementia ALS-FTD.27 
However five participants with ALS met the criteria for 
ALS-FTSD: one with ALS cognitive and behavioural impairment 
and four with ALS cognitive impairment. Six of the participants 
with ALS had abnormal subscores but did not meet the criteria 
for ALS cognitive impairment, and one patient had an isolated 
borderline language subscore.
Neurite orientation dispersion and density imaging
In the whole brain analysis of NODDI parameters, NDI was 
reduced in the ALS group bilaterally within a large continuous 
region of the CST extending from the posterior limb of the 
internal capsule rostrally through the corona radiata into the 
subcortical WM of the PCG (p<0.001) (figure 1 and table 2). 
The area of decreased NDI also extended into the transcallosal 
connection fibres between the primary motor cortices (figure 1A 
and table 2).
A region within the right anterior internal capsule was 
detected where ODI was reduced in the ALS group (p=0.014). 
This contiguous cluster extended into the right PCG (figure 1B 
and table 2).
Finally, ISO was increased within the region of the right lateral 
ventricle (p=0.006) (figure 1C and table 2).
diffusion tensor imaging
In the whole brain analysis of DTI parameters, FA was reduced 
in the ALS group bilaterally within the two regions of the CST: 
the pontine CST (p=0.006) and the superior corona radiata 
and subcortical WM of the PCG (right p<0.001, left p=0.002) 
(figure 2A and table 2).
MD was significantly increased in the ALS group within 
the internal capsule of the left CST (p=0.048) (figure 2B and 
table 2). No changes in MD were detected in the brainstem 
portion of the CST or the corpus callosum.
subgroup analysis using the NoddI parameters
Whole brain analysis for differences between subgroups revealed 
that NDI was significantly reduced in the corona radiata and 
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Figure 1 Figure demonstrating the areas of significant difference between the aLs and control groups on whole brain analysis of the NODDI parameters 
(a) neurite density index (NDI), (B) orientation dispersion index (ODI) and (c) isotropic compartment (IsO). The results are shown using a statistical 
significance of p<0.05 after family-wise error correction at the cluster level, clusters formed using p<0.001. Figures ai - aviii demonstrate the the areas of 
significant difference in NDI on axial sections from the posterior limb of the internal capsule (vi) extending rostrally up into the subcortical WM of the pcG 
(viii).
subcortical WM of the right hemisphere in the subgroup with 
both bulbar and limb involvement, compared with those with 
limb-only involvement (figure 3).
There were no significant differences in ODI or ISO between 
these ALS subgroups.
Correlation of NoddI parameters with disease severity
Using whole brain analysis of NODDI parameters, both ODI 
and ISO showed significant correlation with disease duration. 
ODI correlated with disease duration predominantly in the right 
PCG, but also with a smaller region in the medial aspect of the 
left PCG (see figure 4A). Further areas where ODI correlated 
significantly with disease duration were detected within the 
precuneus and the dorsolateral prefrontal cortex bilaterally. The 
ISO correlated with disease duration in the interhemispheric 
fissure, in close proximity to the paracentral lobule and precu-
neus, as well as the fourth ventricle (see figure 4B).
No significant correlations were found between the NODDI 
parameters and measures of disease severity: ALSFRS-R, 
∆ALSFRS-R, UMN score, MRC power score and ECAS.
dIsCussIoN
The major findings in this study using NODDI in ALS relate, firstly, 
to significant reduction of NDI in the CST and corpus callosum in 
ALS, suggesting loss of axonal density in these pathways. Secondly, 
the reduction of ODI within the PCG in the ALS group and the 
correlation of ODI with disease duration suggest a relationship 
between cortical pathology and the severity of the ALS disease 
process. Finally, our results are consistent with previous DTI 
findings; however, NODDI provides a more definitive interpreta-
tion of the microstructural changes underlying ALS by separating 
neurite density from orientation dispersion.
In relation to the WM changes, the area of reduced NDI extends 
from the posterior limb of the internal capsule and continues 
rostrally into the subcortical WM of the PCG. This supports the 
notion that loss of motor neuron axon density within the cere-
bral WM is a core feature of the neurodegenerative process associ-
ated with ALS, consistent with many pathological studies.28 29 It is 
possible that alterations in glial cells and myelin may also contribute 
to these changes in NDI. However, as the density of axons per 
voxel is much higher than that of glial cells, and loss of motor 
neuron axons is a key feature of ALS, we expect that the largest 
changes are explained by axonal loss.
Regarding reductions in the NDI and ODI in the PCG, we inter-
pret these changes as compatible with the loss of dendritic density 
and reduced dendritic arborisation within the motor cortex, as 
suggested by recent histopathological analyses in humans and 
animal models.30 31 Although changes in cortical dendrites are 
observed at early stages of disease evolution in animal models 
of ALS,32 33 the cortical findings in our cohort using NODDI are 
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Table 2 Regions of significant differences in quantitative diffusion imaging parameters between ALS and control (CTL) groups
Contiguous anatomical regions 
within cluster MNI coordinate (x, y, z) t-Value K (size) PclusterlevelFWe-corr
NDI (ALS<CTL) 
  Right cerebral cortex, precentral 
gyrus
11, −25, 60 5.85 15 344 <0.001
  Right cerebral WM, 
corticospinal tract
22, −22, 46 5.69
  Right posterior limb of the 
internal capsule
23, −12, 7 5.21
  Left posterior limb of the 
internal capsule
−24, −11, 12 6.23 14 005 <0.001
  Left cerebral WM, corticospinal 
tract
−13, −28, 58 5.32
  Left superior corona radiata −20, −20, 41 4.91
ODI (ALS<CTL) 
  Right precentral gyrus 32, 5, 27 3.89 1847 0.014
  Right precentral gyrus 25, −1, 44 3.60
  Right anterior internal capsule 21, 9, 21 3.59
ISO (ALS>CTL) 
  Right caudate, lateral ventricle 11, 18, 4 3.45 2960 0.006
  Right anterior corona radiata 20, 23, 19 3.39
  Right genu of corpus callosum 8, 25, 8 3.30
FA (ALS<CTL) 
  Right precentral gyrus 15, −23, 66 5.10 4097 <0.001
  Right cerebral corticospinal 
tract
26, −23, 49 4.36
  Right superior corona radiata 18, −21, 42 4.19
  Left cerebral WM, corticospinal 
tract
−15, −23, 67 5.25 2877 0.002
  Left cerebral cortex, precentral 
gyrus
−21, −18, 70
−18, −15, 59
4.32
4.08
  Right pons, corticospinal tract 7, −26, −37 5.11 2309 0.006
  Right brainstem, corticospinal 
tract
3, −34, −47 5.10
  Left pons, corticospinal tract −7, −23, −36 4.69
MD (ALS>CTL) 
  Left superior corona radiata −24, −19, 35 4.78 3315 0.048
  Left posterior limb of the 
internal capsule
−18, −15, 3
−20, −17, 14
3.55
3.43
The table shows the anatomical regions where significant changes were demonstrated on whole brain analysis in neurite density index (NDI), orientation dispersion index (ODI), 
isotropic compartment (ISO), fractional anisotropy (FA), and mean diffusivity (MD). A statistical significance threshold of p<0.05 family-wise error (FWE) correction at the cluster 
level (Pcluster) was used, after clusters were formed with an uncorrected p<0.001. Montreal Neurological Institute (MNI) coordinates were used to define the anatomical location 
of each cluster of voxels within the MRI volume. The MNI coordinates refer to the peak t-value. Local maxima that are more than 8 mm apart are shown for each cluster. K 
indicates the size of the cluster in voxels.
ALS, amyotrophic lateral sclerosis; WM, white matter.
limited to a region within the right PCG. It is possible that patho-
logical heterogeneity within the primary motor cortex contributes 
to difficulties in detecting consistent alterations in cortical areas 
using current imaging techniques for whole brain comparisons or 
that loss of cortical dendrites is a relatively late phenomenon in the 
evolution of cerebral pathology in ALS. Nonetheless, these find-
ings indicate that NODDI can reveal new aspects of the cellular 
pathology of diseases such as ALS, in keeping with the recent 
demonstration that changes in NODDI parameters closely reflect 
complex histological changes in the grey matter (GM) and in the 
WM of the spinal cord in multiple sclerosis.13
A direct comparison of the NDI and FA whole brain findings 
in our study shows that NDI detected larger areas of neurode-
generation than FA at the same statistical threshold, where the 
combined cluster sizes for the areas of significantly reduced NDI 
(29 349) were greater than those for areas of significantly reduced 
FA (9283) (see table 2). This suggests that NDI may have a higher 
sensitivity than FA for detecting ALS-related WM pathology and 
also indicates that the primary pathology identified by the diffusion 
MRI signal is alteration in axon density.
In our study FA was reduced into two separate regions of the 
CST in the ALS group, one within the pons and another within 
the corona radiata extending into the subcortical WM of the PCG. 
The CST has previously been implicated in DTI studies demon-
strating reduced FA in the ALS group.34–36 Typically studies report 
reduced FA in one or several isolated regions, including the pons, 
cerebral peduncles, posterior limb of the internal capsule, corona 
radiata and the subcortical WM of the PCG.3 4 35 36 Low FA within 
the corpus callosum is also typically demonstrated in ALS37 but 
not always.4 Rarely are such extensive, contiguous changes demon-
strated throughout the CST and corpus callosum, as evident with 
our findings of reduced NDI using NODDI.
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Figure 2 Figure demonstrating the areas of significant difference between the aLs and control groups on whole brain analysisof DTI parameters (a) 
fractional anisotropy (Fa) and (B) mean diffusivity (MD). The results are shown using a statistical significance of p<0.05 after family-wise error correction at 
the cluster level, clusters formed using p<0.001.
Figure 3 Figure showing the region of significant difference in NDI on whole brain analysis between the bulbar plus limb aLs group and the limb-
confined aLs group. The results are shown for p<0.05 after family-wise error correction at the cluster level, clusters formed using p<0.001.
We found increased MD in the ALS group within the left internal 
capsule, which is consistent with previous studies.3 Reports of 
increased MD have been less consistent than FA findings in ALS, 
which may be explained by the known dependency of MD on the 
specific b-value used for the acquisition.26 In this study, we used 
a maximum b-value of 2400 smm−2, which is higher than typical 
DTI protocols and may account for our findings. We could have 
restricted our DTI analysis to the inner shell (b=800) data to make 
it more compatible with other DTI studies. However this would 
have made the comparison with NODDI (fitted with the full data 
set) unfair. In general the extent of WM changes we found using 
DTI is somewhat reduced compared with other studies.3 4 34–37 
This might be the consequence of specific methodological differ-
ences, the relatively small sample size or the clinical heterogeneity 
of the cohort.
NODDI facilitates the interpretation of the altered diffusivity 
profile in ALS observed using DTI where axonal loss, demonstrated 
by reduced NDI in the CST and corpus callosum, is likely to be the 
main contributing factor for the reduced FA and increased MD. 
We detected reduced ODI in the right internal capsule, a region 
where there is crossing of WM pathways. This could be explained 
by the predominant degeneration of axonal fibres in one direction, 
thereby reducing crossing of fibres in this region. Furthermore, this 
may contribute to the lack of changes in FA detected in this region 
as the corresponding FA may not change due to the remaining 
fibres becoming more coherent, despite axonal degeneration.
Increased ISO was detected within the right lateral ventricle, 
likely representing atrophy in ALS, leading to increased CSF spaces.
When subgroup analysis was performed, the ALS subgroup with 
both bulbar and limb involvement showed loss of right CST axon 
density significantly greater than the group with limb-confined 
ALS. This is in keeping with our hypothesis that more widespread 
clinical involvement in ALS relates to more extensive microstruc-
tural damage.
Regression analysis revealed that both ODI and ISO correlated 
with disease duration, where regions of the right PCG and inter-
hemispheric fissure were involved, respectively. This suggests that 
loss of cortical dendrites and related cerebral atrophy are occurring 
alongside axonal degeneration. The correlation of ODI in the PCG 
with disease duration provides support for the rationale that loss 
of complex neuropil architecture within the motor cortex is occur-
ring in ALS over time.
Clinical heterogeneity of the ALS participants in this study was 
considerable, which could explain why we failed to detect a signif-
icant group difference in more regions of the PCG. A larger study 
using a more homogeneous ALS phenotype may be required in 
order to achieve this on whole brain analysis of ODI. Although 
statistically significant cortical GM changes in ODI and NDI were 
limited to a region within the right PCG, these abnormalities could 
be more relevant to the site and severity of disease. Moreover, the 
topographical pattern of disease within the PCG in ALS is likely 
to have a larger spread of regions involved, with higher variability 
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Figure 4 Figure showing the areas of correlation on whole brain analysis of NODDI parameters and measures of disease severity. (a) areas of correlation 
between orientation dispersion index and disease duration. (B) areas of correlation between isotropic compartment and disease duration. The results are 
shown for p<0.05 after family-wise error correction at the cluster level, clusters formed using p<0.001.
between patients, when compared with the converging axons of 
the CST, the common output pathway of all cortical motor fibres. 
This reduces the detection of significant differences on whole 
brain analysis, which may therefore only become more apparent in 
larger cohorts. Although the GM results are not as strong as those 
obtained in the WM, they nevertheless support the hypothesis of 
dendritic abnormalities paralleling disease progression.
We recognise that there are limitations related to the technique 
used in this study. NODDI may not separate the effects of orienta-
tion dispersion and neurite density effectively within the GM and 
may therefore not fully distinguish intracortical neuropil pathology 
in ALS.38 More recently developed quantitative diffusion MRI 
techniques, incorporating microscopic anisotropy mapping, may 
separate different signal components better and highlight differ-
ences more effectively39 40 but would require additional imaging 
sequences that are not yet available clinically. The NODDI tech-
nique used in this study11 models orientation dispersion isotropi-
cally and may therefore be limited in its capacity to model multiple 
fibre orientations arising from complex dendritic structures.7 
NODDI has subsequently been developed further to incorporate 
a quantification of anisotropic orientation dispersion, and analysis 
using this more sophisticated modelling system is warranted in 
future studies in ALS.12
We used whole brain voxel-wise analysis, which does not require 
any a priori hypotheses and provides information about changes 
in both WM and GM. Although whole brain analysis is prone 
to potential biases due to interindividual anatomical variation 
and partial volume effects, NODDI has the advantage over DTI 
of explicitly modelling the free water (isotropic) component and 
should therefore be less susceptible to the partial volume contam-
ination of CSF. Alternative processing approaches to whole brain 
analysis, such as tract-based spatial statistics41 and GM special 
statistics,14 have been optimised to minimise the potential sources 
of error and to detect changes in WM and GM, respectively. Trac-
tometry, which maps quantitative indices (such as those derived 
from NODDI) to points of streamlines reconstructed by diffusion 
tractography, is a powerful visualisation tool and can potentially 
give insight into the regions of degeneration but suffers from well-
known limitations.42
It should also be noted that many of the studies using NODDI14 15 
were performed at 3T, while our data were performed at 1.5T. The 
field strength has obvious implication for the signal to noise ratio 
(SNR). However, the reduced signal intensity at 1.5T is partially 
compensated by the longer T2 relaxation time at this field strength. 
We used a voxel size of 2.5 mm3, which is almost twice as large as 
that used in the original NODDI paper11 at 3T, and should ensure 
a comparable SNR at the price of reduced spatial resolution.
Another limitation is the sample size, which is particularly rele-
vant given emerging insights into disease heterogeneity in ALS.1 
Nevertheless, our findings illustrate the potential for NODDI to 
interrogate hitherto undetectable details of cellular pathology of 
ALS in life.
We conclude that NODDI reveals evidence compatible with 
structural damage in the PCG in ALS, provides new insights into 
the cellular pathology of WM damage, and demonstrates that 
reduced density of corticospinal axons is the main contributing 
factor underlying the altered diffusivity profile detected by DTI. 
Our observations are compatible with relatively early involvement 
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of cortical neuropil including dendrites in ALS. More exten-
sive longitudinal studies in larger phenotypically and genetically 
defined cohorts will be needed to refine further studies on the 
cortical microstructure in ALS using NODDI and developments 
thereof.
Acknowledgements The authors would like to thank all the participants who 
contributed to this study.
Contributors as clinical research fellow, RJB recruited and consented 
participants, performed all clinical assessments, supervised imaging, and processed 
and interpreted the data. RJB also constructed the first draft of this article and 
prepared all of the figures. McG performed the data preprocessing and advised 
on statistical analysis. NGD designed the NODDI pipeline for the institution and 
provided supervision to RJB and McG in data preprocessing. DJs, aKs, hZ and Dca 
contributed to the design of the study and contributed to the drafting of the paper. 
hZ and Dca provided the necessary skills underpinning NODDI, advised on the 
development of the hypothesis and contributed to writing the funding proposal. They 
also advised on data interpretation and on all drafts of the paper. Mc contributed 
to the design of the study, and to developing and submitting the funding proposal, 
and designed and implemented the imaging protocol. Mc also provided supervision 
for the data processing and analysis, and revised the drafts of the paper at all 
stages. pNL was chief investigator for this study. pNL screened the subjects with 
aLs recruited through the sussex aLs clinical service. pNL and Mc conceived the 
hypotheses and submitted the funding proposal, supervised the clinical research 
fellow (RJB) and oversaw all aspects of the study including ethics and research 
governance. pNL edited and revised the drafts of the paper at all stages. all authors 
reviewed and accepted the final manuscript.
Funding This study was supported by a grant from the Motor Neurone Disease 
association of england and Northern Ireland (Reference: Leigh/apr14/824/791). 
epsRc grants N018702 and M020533 support Dca’s work on this topic.
Competing interests None declared.
Patient consent Obtained.
ethics approval Favourable ethical opinion was awarded by the National health 
service Research ethics committee London (14/LO/0195).
Provenance and peer review Not commissioned; externally peer reviewed.
open access This is an open access article distributed in accordance with the 
creative commons attribution Non commercial (cc BY-Nc 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. see: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/
RefeRences
 1 van es Ma, hardiman O, chio a, et al. amyotrophic lateral sclerosis. Lancet 
2017;390:2084–98.
 2 cavanagh JB. The problems of neurons with long axons. Lancet 1984;1:1284–7.
 3 ellis cM, simmons a, Jones DK, et al. Diffusion tensor MRI assesses corticospinal tract 
damage in aLs. Neurology 1999;53:1051–8.
 4 canu e, agosta F, Riva N, et al. The topography of brain microstructural damage in 
amyotrophic lateral sclerosis assessed using diffusion tensor MR imaging. AJNR Am J 
Neuroradiol 2011;32:1307–14.
 5 Jelescu IO, Veraart J, Fieremans e, et al. Degeneracy in model parameter estimation for 
multi-compartmental diffusion in neuronal tissue. NMR Biomed 2016;29:33–47.
 6 Vos sB, Jones DK, Jeurissen B, et al. The influence of complex white matter 
architecture on the mean diffusivity in diffusion tensor MRI of the human brain. 
Neuroimage 2012;59:2208–16.
 7 Jeurissen B, Leemans a, Tournier JD, et al. Investigating the prevalence of complex 
fiber configurations in white matter tissue with diffusion magnetic resonance imaging. 
Hum Brain Mapp 2013;34:2747–66.
 8 ennis DB, Kindlmann G. Orthogonal tensor invariants and the analysis of diffusion 
tensor magnetic resonance images. Magn Reson Med 2006;55:136–46.
 9 Jespersen sN, Kroenke cD, Østergaard L, et al. Modeling dendrite density from 
magnetic resonance diffusion measurements. Neuroimage 2007;34:1473–86.
 10 Jespersen sN, Leigland La, cornea a, et al. Determination of axonal and dendritic 
orientation distributions within the developing cerebral cortex by diffusion tensor 
imaging. IEEE Trans Med Imaging 2012;31:16–32.
 11 Zhang h, schneider T, Wheeler-Kingshott ca, et al. NODDI: practical in vivo neurite 
orientation dispersion and density imaging of the human brain. Neuroimage 
2012;61:1000–16.
 12 Tariq M, schneider T, alexander Dc, et al. Bingham-NODDI: mapping 
anisotropic orientation dispersion of neurites using diffusion MRI. Neuroimage 
2016;133:207–23.
 13 Grussu F, schneider T, Tur c, et al. Neurite dispersion: a new marker of multiple 
sclerosis spinal cord pathology? Ann Clin Transl Neurol 2017;4:663–79.
 14 Nazeri a, chakravarty MM, Rotenberg DJ, et al. Functional consequences of neurite 
orientation dispersion and density in humans across the adult lifespan. J Neurosci 
2015;35:1753–62.
 15 Kamagata K, hatano T, Okuzumi a, et al. Neurite orientation dispersion and 
density imaging in the substantia nigra in idiopathic parkinson disease. Eur Radiol 
2016;26:2567–77.
 16 colgan N, siow B, O’callaghan JM, et al. application of neurite orientation dispersion 
and density imaging (NODDI) to a tau pathology model of alzheimer’s disease. 
Neuroimage 2016;125:739–44.
 17 adluru G, Gur Y, anderson Js, et al. assessment of white matter microstructure in 
stroke patients using NODDI. Conf Proc IEEE Eng Med Biol Soc 2014;2014:742–5.
 18 Winston Gp, Micallef c, symms MR, et al. advanced diffusion imaging sequences 
could aid assessing patients with focal cortical dysplasia and epilepsy. Epilepsy Res 
2014;108:336–9.
 19 Rae cL, Davies G, Garfinkel sN, et al. Deficits in neurite density underlie white matter 
structure abnormalities in first-episode psychosis. Biol Psychiatry 2017;82:716–25.
 20 Fogarty MJ, Noakes pG, Bellingham Mc. Motor cortex layer V pyramidal neurons 
exhibit dendritic regression, spine loss, and increased synaptic excitation in the 
presymptomatic hsOD1(G93a) mouse model of amyotrophic lateral sclerosis. J 
Neurosci 2015;35:643–7.
 21 herms J, Dorostkar MM. Dendritic spine pathology in neurodegenerative diseases. 
Annu Rev Pathol 2016;11:221–50.
 22 cedarbaum JM, stambler N, Malta e, et al. The aLsFRs-R: a revised aLs functional 
rating scale that incorporates assessments of respiratory function. BDNF aLs study 
Group (phase III). J Neurol Sci 1999;169:13–21.
 23 abrahams s, Newton J, Niven e, et al. screening for cognition and behaviour changes 
in aLs. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:9–14.
 24 Medical Research council. Aids to the investigation of the peripheral nerve injuries. 
her majesty's stationary office, 1976.
 25 Reese TG, heid O, Weisskoff RM, et al. Reduction of eddy-current-induced distortion in 
diffusion MRI using a twice-refocused spin echo. Magn Reson Med 2003;49:177–82.
 26 Leemans a, Jones DK. The B-matrix must be rotated when correcting for subject 
motion in DTI data. Magn Reson Med 2009;61:1336–49.
 27 strong MJ, abrahams s, Goldstein Lh, et al. amyotrophic lateral sclerosis - 
frontotemporal spectrum disorder (aLs-FTsD): revised diagnostic criteria. Amyotroph 
Lateral Scler Frontotemporal Degener 2017;18:153–74.
 28 Brownell B, Oppenheimer DR, hughes JT. The central nervous system in motor neurone 
disease. J Neurol Neurosurg Psychiatry 1970;33:338–57.
 29 smith Mc. Nerve fibre degeneration in the brain in amyotrophic lateral sclerosis. J 
Neurol Neurosurg Psychiatry 1960;23:269–82.
 30 Genç B, Jara Jh, Lagrimas aK, et al. apical dendrite degeneration, a novel cellular 
pathology for Betz cells in aLs. Sci Rep 2017;7:41765.
 31 Fogarty MJ, Mu eW, Noakes pG, et al. Marked changes in dendritic structure and 
spine density precede significant neuronal death in vulnerable cortical pyramidal 
neuron populations in the sOD1(G93a) mouse model of amyotrophic lateral sclerosis. 
Acta Neuropathol Commun 2016;4:77.
 32 Fogarty MJ, Klenowski pM, Lee JD, et al. cortical synaptic and dendritic spine 
abnormalities in a presymptomatic TDp-43 model of amyotrophic lateral sclerosis. Sci 
Rep 2016;6:37968.
 33 Jara Jh, Villa sR, Khan Na, et al. aaV2 mediated retrograde transduction of 
corticospinal motor neurons reveals initial and selective apical dendrite degeneration 
in aLs. Neurobiol Dis 2012;47:174–83.
 34 Iwata NK, Kwan JY, Danielian Le, et al. White matter alterations differ in primary 
lateral sclerosis and amyotrophic lateral sclerosis. Brain 2011;134(pt 9):2642–55.
 35 agosta F, Valsasina p, Riva N, et al. The cortical signature of amyotrophic lateral 
sclerosis. PLoS One 2012;7:e42816.
 36 Zhang Y, schuff N, Woolley sc, et al. progression of white matter degeneration in 
amyotrophic lateral sclerosis: a diffusion tensor imaging study. Amyotroph Lateral 
Scler 2011;12:421–9.
 37 Filippini N, Douaud G, Mackay ce, et al. corpus callosum involvement is a consistent 
feature of amyotrophic lateral sclerosis. Neurology 2010;75:1645–52.
 38 Lampinen B, szczepankiewicz F, Mårtensson J, et al. Neurite density imaging versus 
imaging of microscopic anisotropy in diffusion MRI: a model comparison using 
spherical tensor encoding. Neuroimage 2017;147:517–31.
 39 shemesh N, cohen Y. Microscopic and compartment shape anisotropies in gray 
and white matter revealed by angular bipolar double-pFG MR. Magn Reson Med 
2011;65:1216–27.
 40 szczepankiewicz F, Lasič s, van Westen D, et al. Quantification of microscopic 
diffusion anisotropy disentangles effects of orientation dispersion from 
microstructure: applications in healthy volunteers and in brain tumors. Neuroimage 
2015;104:241–52.
 41 smith sM, Jenkinson M, Johansen-Berg h, et al. Tract-based spatial statistics: 
voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487–505.
 42 campbell Js, pike GB. potential and limitations of diffusion MRI tractography for the 
study of language. Brain Lang 2014;131:65–73.
copyright.
 o
n
 1 N
ovem
ber 2018 by guest. Protected by
http://jnnp.bmj.com/
J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp-2018-318830 on 25 October 2018. Downloaded from 
